Strategic Plan
Strategic Plan (2025–2028)
Pain Relief International – Free Reusable Pain Relief Device Initiative
1. Vision
To eliminate unnecessary pain for underserved, low-income individuals globally by distributing innovative, non-invasive, drug-free pain relief devices powered by NeuroCuple® technology, in alignment with the Sustainable Development Goals of the United Nations, the World Bank, and other international partners.
2. Mission
We partner with NGOs, government agencies, community organizations, international bodies, funders, and inventors to mobilize resources, distribute patented NeuroCuple® devices, and ensure sustained impact, especially among communities with limited access to conventional pain management.
3. Core Values
-
Compassion — Centering human dignity in all our work; serving those with the greatest need.
-
Innovation — Constantly refining our technology, delivery, and support methods.
-
Collaboration — Leveraging partnerships locally and globally to maximize reach and effectiveness.
-
Excellence — Setting high standards for all operations: quality, ethics, transparency.
-
Sustainability — Environmental responsibility, long device lifespans, and sustainable funding models.
-
Respect & Equity — Ensuring fairness, cultural sensitivity, and inclusion in all our initiatives.
4. Strategic Goals (2025–2028)
Goal Area | Target Metric(s) | Timeline |
---|---|---|
Fundraising | Raise $50 million by end of 2028. | Annual targets: $10M in 2025; $12M in 2026; $14M in 2027; $14M in 2028. |
Device Distribution | Provide 4 million reusable NeuroCuple® devices (80,000 per $1M raised). | Scale distribution year by year: 800k in 2025; 1M in 2026; 1.2M in 2027; 1M in 2028. |
Impact & Learning | Collect robust data showing at least 80% of users report significant pain relief; publish results annually. | Baseline in 2025; midterm in 2026; full evaluation in 2028. |
Partnership Growth | Build partnerships with 25+ global agencies and 100+ local organizations. | Expand 5–7 global partners per year. |
Technology Enhancement | Extend device life beyond 10 years; improve usability and comfort. | First design update by 2025; refinements annually. |
Sustainability & Manufacturing | Establish at least 5 local manufacturing hubs to reduce costs, create jobs, and shorten supply chains. | Launch first hub in 2026; all 5 operating by 2028. |
5. Strategies for Achieving Goals
5.1 Fundraising Strategy
-
Pursue grants from global health funds, multilateral institutions, and foundations.
-
Partner with corporations for co-branded campaigns.
-
Engage major donors for transformational gifts.
-
Scale grassroots fundraising via storytelling, social media, and donor clubs.
5.2 Distribution Strategy
-
Prioritize regions with highest unmet pain needs.
-
Partner with Ministries of Health, NGOs, and local clinics for deployment.
-
Leverage “train-the-trainer” education for sustainable local knowledge.
-
Maintain robust logistics and device tracking.
5.3 Impact & Learning Strategy
-
Conduct surveys and follow-ups with beneficiaries at 3, 6, and 12 months.
-
Document and publish case studies and annual reports.
-
Use findings to refine technology and distribution.
5.4 Technology Improvement Strategy
-
Enhance materials for comfort and durability.
-
Explore multiple form factors to meet diverse needs (neck, back, waist, extremities).
-
Collect ongoing feedback from the field.
5.5 Sustainability & Local Manufacturing Strategy
-
Establish regional production hubs to reduce shipping costs and carbon footprint.
-
Create thousands of local jobs tied to device production and distribution.
-
Implement eco-friendly packaging and supply chain practices.
6. Implementation & Governance
-
Leadership Council: Oversees strategic plan execution.
-
Regional Hubs: Coordinate logistics, training, and monitoring.
-
Operational Workplans: Annual budgets and quarterly milestones tied to KPIs.
7. Risk Management
Risk | Likelihood | Impact | Mitigation |
---|---|---|---|
Funding shortfall | Medium | High | Maintain reserves, diversify sources, build multi-year pledges. |
Supply chain issues | Medium | High | Develop local hubs, diversify suppliers, stockpile. |
Regulatory/policy barriers | Medium | High | Engage governments early, ensure compliance. |
Technology acceptance | Low-Med | Medium | Pilot programs, strong user training, feedback loops. |
8. Monitoring & Review
-
Quarterly internal reports, annual public reports.
-
Independent external evaluation every 2 years.
-
Midterm review in 2026 to adjust strategies as needed.
9. Call To Action
With your support, $50 million = 4 million devices placed into the hands of people in need. Each device provides years of drug-free relief, helping families, communities, and health systems focus resources where they are needed most.
Join us — as a partner, donor, or advocate — and together we can make pain relief a human right for billions.